Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Fierce Biotech37m
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
pharmaphorum43m
Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Alphabet’s AI Drug Unit Raises $600 Million From OpenAI Backer
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...
Alphabet-backed Isomorphic Labs bags $600 million funding to build next-gen AI drug design engine
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT ...
Google DeepMind CEO says his passion for chess led to his career in AI
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.
Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance
LONDON, March 31, 2025 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding round. The financing ...
University of Cambridge7d
Nobel laureate and Cambridge alumnus Sir Demis Hassabis heralds a new era of 'digital speed' drug discovery
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
Shacknews13d
Google Deepmind CEO believes artificial general intelligence (AGI) will emerge in next decade
Demis Hassabis believes it could even be as soon as 5 years that AI models are able to match human quality in every task.
Alphabet's AI drug unit Isomorphic Labs raises $600 mn from OpenAI backer
Alphabet created Isomorphic Labs in 2021, spinning it out from DeepMind, the AI startup it acquired in 2014. DeepMind’s ...